Abstract
A transgenic mouse (Tg), having the human c‐Ha‐ras proto‐oncogene, has been demonstrated to develop hemangioendothelial sarcomas (HESs) which are associated with the transgene mutation, but not to develop liver tumors. In this study, we examined the effects of 2‐amino‐6‐methyldipyrido [1,2‐a:3′,2′‐d] imidazole (Glu‐P‐1), a food‐borne carcinogen, which has been demonstrated to induce HESs and liver tumors in CDF1 mice, on Tg mice. Chronic administration of 0.05% Glu‐P‐1 in the diet induced HESs in Tg (7/17), but not in 18 non‐transgenic mice (N‐Tg). With basal diet, two out of 17 Tg but none of 22 N‐Tg, developed HESs. In contrast, Glu‐P‐1 administration induced liver tumors, both in Tg and in N‐Tg; 16/17 in Tg and 13/18 in N‐Tg. The incidence of hepatocellular carcinomas in Tg was higher than that in N‐Tg (8/17 versus 3/18). With basal diet, only one out of 17 Tg and none of 22 N‐Tg developed liver tumors. The Ha‐ras mutation in tumors developed by the groups administered Glu‐P‐1, was examined. No mutations were detected in the transgene and mouse c‐Ha‐ras genes in all three HESs examined. In contrast, when 29 liver tumors taken from Tg were examined, two mutations of the transgene were detected in two HCCs. No mouse c‐Ha‐ras gene mutations were detected in any of the 47 liver tumors examined, which had developed in Tg and N‐Tg mice. These results suggest that the transgene plays a role in the development of HESs induced by Glu‐P‐1, but not as a result of its mutation. Futher, the transgene plays no significant role in the development of liver tumors induced by Glu‐P‐1, but does play a role in the malignant conversion of some liver tumors, as a result of its mutation.
Keywords: Ha‐ras Tg mouse, c‐Ha‐ras mutation, Glu‐P‐1, Liver tumor, Hemangioendothelial sarcoma
Full Text
The Full Text of this article is available as a PDF (343.0 KB).
REFERENCES
- 1. ) Saitoh , A. , Kimura , M. , Takahashi , R. , Yokoyama , M. , Nomura , T. , Izawa , M. , Sekiya , T. , Nishimura , S. and Katsuki , M.Most tumors in transgenic mice with human c‐Ha‐ras gene contained somatically activated transgenes . Oncogene , 5 , 1195 – 2000 ( 1990. ). [PubMed] [Google Scholar]
- 2. ) Ando , K. , Saitoh , A. , Hino , O. , Takahashi , R. , Kimura , M. and Katsuki , M.Chemically induced forestomach papillomas in transgenic mice carry mutant human c‐Ha‐ras transgenes . Cancer Res. , 52 , 978 – 982 ( 1992. ). [PubMed] [Google Scholar]
- 3. ) Doi , S.‐T. , Kimura , M. and Katsuki , M.Site‐specific mutation of the human c‐Ha‐ras transgene induced by dimethylbenzanthracene causes tissue‐specific tumors in mice . Jpn. J. Cancer Res. , 85 , 801 – 807 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. ) Ohgaki , H. , Matsukura , N. , Morino , K. , Kawachi , T. , Sugimura , T. and Takayama , S.Carcinogenicity in mice of mutagenic compounds from glutamic acid and soybean globulin pyrolysates . Carcinogenesis , 5 , 815 – 819 ( 1984. ). [DOI] [PubMed] [Google Scholar]
- 5. ) Sambrook , J. , Fritsch , E. F. and Maniatis , T.Isolation of high‐molecular‐weight DNA from mammalian cells . In “ Molecular Cloning, A Laboratory Manual ,” ed. Ford N. , Nolan C. and Ferguson M. , pp. 9.14 – 9.23 ( 1989. ). Cold Spring Harbor Laboratory Press; , New York . [Google Scholar]
- 6. ) Sekiya , T. , Fushimi , M. , Hori , H. , Hirohashi , S. , Nishimura , S. and Sugimura , T.Molecular cloning and total nucleotide sequence of the human c‐Ha‐ras‐1 gene activated in a melanoma from a Japanese patient . Proc. Natl. Acad. Sci. USA , 81 , 4771 – 4775 ( 1984. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. ) Yuasa , Y. , Srivastava , S. K. , Dunn , C. Y. , Rhim , J. S. , Reddy , E. P. and Aaronson , S. A.Acquisition of transforming properties by alternative point mutations within c‐bas/has human proto‐oncogene . Nature , 303 , 775 – 779 ( 1983. ). [DOI] [PubMed] [Google Scholar]
- 8. ) Tsunematsu , S. , Saito , H. , Kagawa , T. , Morizane , T. , Hata , J. , Nakamura , T. , Ishii , H. , Tsuchiya , M. , Nomura , T. and Katsuki , M.Hepatic tumors induced by carbon tetrachloride in transgenic mice carrying a human c‐Ha‐ras proto‐oncogene without mutations . Int. J. Cancer , 59 , 554 – 559 ( 1994. ). [DOI] [PubMed] [Google Scholar]
- 9. ) Kato , T. , Hasegawa , R. , Imaida , K. , Doi , T. , Kimura , M. , Katsuki , M. and Ito , N.Analysis of carcinogenesis induced by different agents using transgenic mice carrying human proto c‐H‐ras genes . Proc. Jpn. Cancer Assoc., 51th Annu. Meet. , 47 ( 1992. ).